Arkolith/Insider Trading/RGNX/Form 4

Pakola Steve

Chief Medical OfficerREGENXBIO Inc. (RGNX) · full profile →Form 4 · filed Jul 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$29K
Net Open-Market Flow
-$29K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 2, 2026Option exercise(M)2K$7.86$17K215K
Jul 2, 2026Sell(S)2K$13.64$29K213K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 2, 2026Option exercise(M)2K—$065K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001700659-26-000014) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for REGENXBIO Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp